2002
DOI: 10.1074/jbc.m201597200
|View full text |Cite
|
Sign up to set email alerts
|

Smooth Muscle Myosin Phosphatase-associated Kinase Induces Ca2+ Sensitization via Myosin Phosphatase Inhibition

Abstract: Introduction of recombinant MYPT1 kinase elicited a calcium-independent contraction in ␤-escin-permeabilized rabbit ileal smooth muscle. Using an antibody that specifically recognizes MYPT1 phosphorylated at Thr 654 (M130 numbering), we determined that this calcium-independent contraction was correlated with an increase in MYPT1 phosphorylation. These results indicate that SMPP-1M phosphorylation by MYPT1 kinase is a mechanism of smooth muscle calcium sensitization.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
102
2
1

Year Published

2004
2004
2022
2022

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 87 publications
(108 citation statements)
references
References 32 publications
3
102
2
1
Order By: Relevance
“…When phosphorylated by PKC, CPI-17 becomes a potent inhibitor of type 1 protein Ser/Thr phosphatases, such as myosin phosphatase PP1. CPI-17 may also be phosphorylated by RhoK (31), by ILK (24), and by ZIP-like kinase (8).…”
Section: Intermediate Proteinsmentioning
confidence: 99%
See 1 more Smart Citation
“…When phosphorylated by PKC, CPI-17 becomes a potent inhibitor of type 1 protein Ser/Thr phosphatases, such as myosin phosphatase PP1. CPI-17 may also be phosphorylated by RhoK (31), by ILK (24), and by ZIP-like kinase (8).…”
Section: Intermediate Proteinsmentioning
confidence: 99%
“…3): a small 20-kDa subunit of uncertain function (M20), a 38-kDa catalytic subunit, which is a type 1 phosphatase (PP1), and a myosin-targeting subunit (MYPT1) of 110 -133 kDa (9,32). MYPT1 may be phosphorylated by ILK (8), by ZIP-like kinase (8), and in some muscles, MYPT1 may be phosphorylated by Rho kinase (RhoK), inhib-iting phosphatase activity and promoting contraction. RhoK, however, plays no role in ACh-induced contraction of Eso, because the contraction is not affected by either C3, an exoenzyme of Clostridium botulinum that is a specific RhoA inhibitor (14), or by the RhoK inhibitor Y27632 (W. Cao, unpublished observations).…”
Section: Intermediate Proteinsmentioning
confidence: 99%
“…The major site of MYPT1 phosphorylation is Threonine 696 (numbering relates to the human form), which inhibits phosphatase function [57], possibly by blocking the active site or by disrupting interaction of the catalytic subunit with phosphorylated substrate [58]. Kinases that have been reported to phosphorylate Thr696 include: ROCK1 and ROCK2 [57], MRCKa and MRCKb [47,59], ILK [60,61], ZIPK [62] and the DMPK [63]. Phosphorylation of Threonine 853 by ROCK has also been reported to inhibit MLC dephosphorylation by decreasing MLC binding [57,64].…”
Section: Acto-myosin Contractionmentioning
confidence: 99%
“…The Thr-697 site of MYPT1 (rat sequence) has been identified as a key inhibitory phosphorylation site for the regulation of MLCP activity. Rho-associated kinase (ROK) (25), zipper-interacting protein kinase (ZIPK) (3,24,34,40), and integrin-linked kinase (ILK) (28, 39) have been demonstrated to phosphorylate MYPT1 at this inhibitory site. In addition, ROK (32), ZIPK (35), and ILK (9) contribute indirectly to MLCP inhibition by playing a role in CPI-17 phosphorylation.…”
Section: ϩmentioning
confidence: 99%